Terumo Co. (OTCMKTS:TRUMY) Short Interest Down 34.5% in February

Terumo Co. (OTCMKTS:TRUMY) was the target of a large decline in short interest in February. As of February 15th, there was short interest totalling 14,800 shares, a decline of 34.5% from the January 31st total of 22,600 shares. Based on an average daily volume of 208,500 shares, the days-to-cover ratio is presently 0.1 days.

Terumo Price Performance

Shares of TRUMY opened at $17.88 on Tuesday. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.70 and a current ratio of 2.94. The company has a 50 day moving average price of $18.72 and a 200-day moving average price of $19.13. Terumo has a fifty-two week low of $14.06 and a fifty-two week high of $21.22. The stock has a market capitalization of $26.47 billion, a PE ratio of 36.95 and a beta of 0.64.

Terumo (OTCMKTS:TRUMY) last announced its earnings results on Thursday, February 13th. The company reported $0.16 earnings per share (EPS) for the quarter. The company had revenue of $1.73 billion for the quarter.

About Terumo

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company.